Sygnis
德國Sygnis制藥公司的旗艦產品Qualiphi是一個可用于完整DNA擴增的聚合酶,是長DNA片段和全基因組擴增的主要工具之一。
SYGNIS Pharma AG is a biotech company listed in the Prime Standard of the German Stock Exchange. According to the 2012 newly defined business strategy, the company focuses on the development and marketing of novel technologies in molecular biology, e.g. in the field of DNA amplification and sequencing. For the key product “Qualiphi?”, an improved polymerase for amplifying DNA, an exclusive worldwide license has been granted to Qiagen in July 2012.